See today's BioWorld Science
To read the full story, subscribe or sign in.
Dermatologic

Attovia Therapeutics to use financing to advance Attobody pipeline

Feb. 9, 2024
Attovia Therapeutics Inc. has announced the closing of the $30 million second tranche of its $60 million series A financing.
BioWorld Science Financings Cancer Dermatologic Gastrointestinal Respiratory Series A